<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle">
<p class="DocumentTitle"><strong>POTASSIUM PHOSPHATES- potassium phosphate, monobasic and potassium phosphate, dibasic injection, solution </strong><br>American Regent, Inc.<br></p>
<p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm">For further information about unapproved drugs, click here.</a></p>
</div>
<h1>POTASSIUM PHOSPHATES<br>INJECTION, USP<br>(3 mM PHOSPHORUS/mL 4.4 mEq POTASSIUM/mL)<br>Osmolarity 7.4 mOsmol/mL
</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="dcl-dpl"></a><a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s1"></a><a name="section-1"></a><p></p>
<p class="First"><span class="Bold">Rx Only</span></p>
<p><span class="Bold">CAUTION: FOR INTRAVENOUS USE ONLY<br>                MUST BE DILUTED PRIOR TO ADMINISTRATION</span></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="s2"></a><a name="section-2"></a><p></p>
<h1>DESCRIPTION:
</h1>
<p class="First">Potassium Phosphates Injection, USP is a sterile, nonpyrogenic, concentrated solution containing a mixture of monobasic and dibasic potassium phosphate in Water for Injection. It must be diluted prior to administration.
</p>
<p>Each mL of the solution consists of two phosphate salts provided as follows:
</p>
<table width="100%">
<col align="left" width="34.133%">
<col align="left" width="34.800%">
<col align="left" width="31.067%">
<tbody class="Headless">
<tr class="First">
<td class="Botrule Lrule Rrule Toprule" align="center" valign="top"><span class="Bold">Ingredient(s)</span></td>
<td class="Botrule Rrule Toprule" align="center" valign="top"><span class="Bold">Phosphorus</span></td>
<td class="Botrule Rrule Toprule" align="center" valign="top"><span class="Bold">Potassium</span></td>
</tr>
<tr>
<td class="Lrule Rrule" align="center" valign="top">Monobasic Potassium
</td>
<td class="Rrule" align="center" valign="top">93 mg
</td>
<td class="Rrule" align="center" valign="top">170 mg
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="center" valign="top">Phosphate -224 mg
</td>
<td class="Rrule" align="center" valign="top"></td>
<td class="Rrule" align="center" valign="top"></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="center" valign="top">Anhydrous
</td>
<td class="Rrule" align="center" rowspan="2" valign="top">or
</td>
<td class="Rrule" align="center" rowspan="2" valign="top">or
</td>
</tr>
<tr><td class="Lrule Rrule" align="center" valign="top">Dibasic Potassium
</td></tr>
<tr>
<td class="Lrule Rrule" align="center" valign="top">Phosphate -236 mg
</td>
<td class="Rrule" align="center" valign="top">3 mM
</td>
<td class="Rrule" align="center" valign="top">4.4 mEq
</td>
</tr>
<tr class="Last">
<td class="Botrule Lrule Rrule" align="center" valign="top">Anhydrous
</td>
<td class="Botrule Rrule" align="center" valign="top"></td>
<td class="Botrule Rrule" align="center" valign="top"></td>
</tr>
</tbody>
</table>
<p>The solution contains no bacteriostatic agent or other preservative.
</p>
<p>The solution is intended to provide phosphate ion, (PO<span class="Sub">4</span><span class="Sup">-3</span>) for addition to large volume infusion fluids for intravenous use. Unused portions should be discarded.
</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="s3"></a><a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY:
</h1>
<p class="First">Phosphorus in the form of organic and <span class="product-label-link" type="condition" conceptid="4106483" conceptname="P">inorganic phosphate</span> has a variety of important biochemical functions in the body and is involved in many significant metabolic and enzyme reactions in almost all organs and tissues. It exerts a modifying influence on the steady state of calcium levels, a buffering effect on acid-base equilibrium and a primary role in the renal excretion of hydrogen ion.
</p>
<p>Phosphorus is present in plasma and other extracellular fluid, in cell membranes and intracellular fluid, as well as in collagen and bone. Phosphorus in the extracellular fluid is primarily in inorganic form, and plasma levels may vary somewhat with age.
</p>
<p>The ratio of disodium phosphate and monosodium phosphate in the extracellular fluid is 4:1 (80% : 20%) at the normal pH of 7.4. This buffer ratio varies with the pH, but owing to its relatively low concentration, it contributes little to the buffering-capacity of the extracellular fluids.
</p>
<p>Phosphorus, present in large amounts in erythrocytes and other tissue cells, plays a significant intracellular role in the synthesis of high energy organic phosphates.
</p>
<p><span class="product-label-link" type="condition" conceptid="4177973" conceptname="Hypophosphatemia">Hypophosphatemia</span> should be avoided during periods of total parenteral nutrition, or other lengthy periods of intravenous infusions. Serum phosphorus levels should be regularly monitored, and appropriate amounts of phosphorus should be added to the infusions to maintain normal serum phosphorus levels. Intravenous infusion of inorganic phosphorus may be accompanied by a decrease in the serum level and urinary excretion of calcium. The normal level of serum inorganic phosphorus is 3.0 to 4.5 mg/dL in adults and 4.0 to 7.0 mg/dL in children. Intravenously infused phosphorus not taken up by the tissues is excreted almost entirely in the urine.
</p>
<p>Potassium is the principal intracellular cation. It helps transport dextrose across the cell membrane and contributes to normal renal function.
</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="s4"></a><a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE:
</h1>
<p class="First">Potassium Phosphates Injection, USP, 3 mM P/mL, is indicated as a source of phosphorus, for addition to large volume intravenous fluids, to prevent or correct <span class="product-label-link" type="condition" conceptid="4177973" conceptname="Hypophosphatemia">hypophosphatemia</span> in patients with restricted or no oral intake. It is also useful as an additive for preparing specific intravenous fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. The concomitant amount of potassium (4.4 mEq/mL) must be calculated into total electrolyte content of such prepared solutions.
</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="s5"></a><a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS:
</h1>
<p class="First">Potassium Phosphates Injection is contraindicated in diseases where high potassium, high phosphorus or low calcium levels may be encountered.
</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="s6"></a><a name="section-6"></a><p></p>
<h1>WARNINGS:
</h1>
<p class="First">Potassium Phosphates Injection must be diluted and thoroughly mixed before use.
</p>
<p>To avoid potassium or phosphorus <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">intoxication</span>, infuse solutions containing potassium phosphates slowly. In patients with severe renal or <span class="product-label-link" type="condition" conceptid="193984" conceptname="Adrenal hypofunction">adrenal insufficiency</span>, administration of Potassium Phosphates Injection may cause potassium <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">intoxication</span>. Infusing high concentrations of phosphorus may cause <span class="product-label-link" type="condition" conceptid="435510" conceptname="Hypocalcemia">hypocalcemia</span>, and calcium levels should be monitored.
</p>
<p>Solutions which contain potassium ions should be used with great care if at all, in patients with <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span>, severe <span class="product-label-link" type="condition" conceptid="192359" conceptname="Renal failure syndrome">renal failure</span> and in conditions in which potassium retention is present.
</p>
<p>In patients with diminished renal function, administration of solutions containing potassium ions may result in potassium retention.
</p>
<p>This product contains aluminum that may be toxic. Aluminum may reach toxic levels with prolonged parenteral administration if kidney function is impaired. Premature neonates are particulary at risk because their kidneys are immature, and they require large amounts of calcium and phosphate solutions, which contain aluminum.
</p>
<p>Research indicates that patients with impaired kidney function, including premature neonates, who receive parenteral levels of aluminum at greater than 4 to 5 mcg/kg/day accumulate aluminum at levels associated with central nervous system and bone toxicity. Tissue loading may occur at even lower rates of administration.
</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="s7"></a><a name="section-7"></a><p></p>
<h1>PRECAUTIONS:
</h1>
<p class="First">Phosphorus replacement therapy with potassium phosphates should be guided primarily by the serum inorganic phosphorus levels and the limits imposed by the accompanying potassium (K<span class="Sup">+</span>) ion. Frequent monitoring of serum calcium and potassium as well as renal function is recommended.
</p>
<p>High plasma concentrations of potassium may cause <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span> through cardiac <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span>, <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">arrhythmias</span> or arrest.
</p>
<p>Use with caution in the presence of cardiac disease, particularly in digitalized patients or in the presence of <span class="product-label-link" type="condition" conceptid="198124" conceptname="Kidney disease">renal disease</span>.
</p>
<div class="Section" data-sectionCode="42228-7">
<a name="s8"></a><a name="section-7.1"></a><p></p>
<p class="First"><span class="Bold">Pregnancy:
</span><span class="Underline">Teratogenic Effects.
</span><span class="Italics">Pregnancy Category C.</span> Animal reproduction studies have not been conducted with Potassium Phosphates Injection. It is also not known whether Potassium Phosphates Injection can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity.
</p>
<p>Potassium Phosphates Injection should be given to a pregnant woman only if clearly needed.
</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="s9"></a><a name="section-8"></a><p></p>
<h1>ADVERSE REACTIONS:
</h1>
<p class="First">Adverse reactions involve the possibility of combined potassium and phosphorus <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">intoxication</span> from overdosage. The signs and symptoms of potassium <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">intoxication</span> include <span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">paresthesias</span> of the extremities, <span class="product-label-link" type="condition" conceptid="4193951" conceptname="Flaccid paralysis">flaccid paralysis</span>, <span class="product-label-link" type="condition" conceptid="4071366" conceptname="Indifference">listlessness</span>, <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">mental confusion</span>, <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span> and heaviness of the legs, <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>, <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">cardiac arrhythmias</span>, <span class="product-label-link" type="condition" conceptid="316135" conceptname="Atrioventricular block">heart block</span>, electrocardiographic abnormalities such as disappearance of P waves, spreading and slurring of the <span class="product-label-link" type="condition" conceptid="4064625" conceptname="QRS complex feature">QRS complex</span> with development of a biphasic curve and <span class="product-label-link" type="condition" conceptid="321042" conceptname="Cardiac arrest">cardiac arrest</span>. Phosphorus <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">intoxication</span> results in a reduction of serum calcium, and the symptoms are those of <span class="product-label-link" type="condition" conceptid="380534" conceptname="Tetany">hypocalcemic tetany</span>. See <span class="Bold"><a href="#s6">WARNINGS</a></span>.
</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="s10"></a><a name="section-9"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION:
</h1>
<p class="First">Potassium Phosphates Injection is administered intravenously <span class="Underline">only after dilution in a larger volume of fluid</span>. The dose and rate of administration are dependent upon the individual needs of the patient. Serum potassium, inorganic phosphorus and calcium levels should be monitored as a guide to dosage.
</p>
<p>Withdraw the calculated volume aseptically and transfer to appropriate intravenous fluid to provide the desired number of millimoles (mM) of phosphorus and milliequivalents (mEq) of potassium.
</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="s11"></a><a name="section-10"></a><p></p>
<h1>OVERDOSAGE:
</h1>
<p class="First">In the event of overdosage, discontinue infusions containing potassium phosphates immediately, and institute corrective therapy to restore depressed serum calcium and to reduce elevated serum potassium levels. (See <span class="Bold"><a href="#s6">WARNINGS</a>, <a href="#s7">PRECAUTIONS</a></span> and <span class="Bold"><a href="#s9">ADVERSE REACTIONS</a>).</span></p>
<p>Parenteral drug products should be inspected visually for particulate matter and discoloration, whenever solution and container permit.
</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="s12"></a><a name="section-11"></a><p></p>
<h1>HOW SUPPLIED:
</h1>
<p class="First">Potassium Phosphates Injection, USP 3mM Phosphorus/mL, 4.4 mEq Potassium/mL
</p>
<table width="100%">
<col align="left" width="33.333%">
<col align="left" width="33.333%">
<col align="left" width="33.333%">
<tbody class="Headless">
<tr class="First">
<td align="left" valign="top">NDC 0517-2305-25
</td>
<td align="left" valign="top">5 mL Single Dose Vial
</td>
<td align="left" valign="top">packed in boxes of 25
</td>
</tr>
<tr>
<td align="left" valign="top">NDC 0517-2315-25
</td>
<td align="left" valign="top">15 mL Single Dose Vial
</td>
<td align="left" valign="top">packed in boxes of 25
</td>
</tr>
<tr class="Last">
<td align="left" valign="top">NDC 0517-2350-25
</td>
<td align="left" valign="top">50 mL Single Dose Vial
</td>
<td align="left" valign="top">packed in boxes of 25
</td>
</tr>
</tbody>
</table>
<p>Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) (See USP Controlled Room Temperature).
</p>
<p>These products do not contain a bacteriostatic agent or other preservatives. Any unused portion should be discarded.
</p>
<p>IN2305<br>Rev. 11/05<br>MG #8654
</p>
<p><span class="Bold">AMERICAN</span><br><span class="Bold">REGENT, INC.</span><br><span class="Bold">SHIRLEY, NY 11967</span></p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="s13"></a><a name="section-12"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - 5 mL Label
</h1>
<p class="First">NDC 0517-2305-25
</p>
<p>POTASSIUM PHOSPHATES INJECTION, USP
</p>
<p>15 mM/5 mL Phosphorus
</p>
<p>22 mEq/5 mL Potassium
</p>
<p>5 mL SINGLE DOSE VIAL
</p>
<p>FOR IV USE AFTER DILUTION
</p>
<p>Rx Only
</p>
<p>AMERICAN REGENT, INC.
</p>
<p>SHIRLEY, NY  11967
</p>
<div class="Figure">
<a name="f01"></a><img alt="PRINCIPAL DISPLAY PANEL 5 mL Label
" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=50936b86-2879-4b88-8b15-895afa82e6bf&amp;name=pot00-0000-01.jpg">
</div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="s14"></a><a name="section-13"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - 5 mL Carton
</h1>
<p class="First">NDC 0517-2305-25
</p>
<p>POTASSIUM PHOSPHATES INJECTION, USP
</p>
<p>15 mM/5 mL Phosphorus
</p>
<p>22 mEq/5 mL Potassium
</p>
<p>25 x 5 mL SINGLE DOSE VIALS
</p>
<p>FOR INTRAVENOUS USE AFTER DILUTION
</p>
<p>Rx Only
</p>
<p>Each mL contains: Potassium Phosphate Monobasic (Anhydrous) 224 mg, Potassium Phosphate Dibasic (Anhydrous) 236 mg, Water for Injection q.s. Sterile, nonpyrogenic.   7.4 mOsmol/mL
</p>
<p>Each mL provides 93mg (3 mM) of Phosphorus and 170 mg (4.4 mEq) of Potassium. 
</p>
<p>WARNING: DISCARD UNUSED PORTION. USE ONLY IF SOLUTION IS CLEAR.
</p>
<p>Store at 20°-25°C (68°-77°F); excursions permitted to 15°-30°C (59°-86°F) (See USP Controlled Room Temperature).Directions for Use: See Package Insert.
</p>
<p>AMERICAN REGENT, INC.
</p>
<p>SHIRLEY, NY  11967
</p>
<p>Rev. 11/05
</p>
<div class="Figure">
<a name="f02"></a><img alt="PRINCIPAL DISPLAY PANEL 5 mL Carton
" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=50936b86-2879-4b88-8b15-895afa82e6bf&amp;name=pot00-0000-02.jpg">
</div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="s15"></a><a name="section-14"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - 15 mL Label
</h1>
<p class="First">NDC 0517-2315-25
</p>
<p>POTASSIUM PHOSPHATES INJECTION, USP
</p>
<p>45 mM/15 mL Phosphorus
</p>
<p>66 mEq/15 mL Potassium
</p>
<p>15 mL SINGLE DOSE VIAL
</p>
<p>FOR IV USE AFTER DILUTION
</p>
<p>Rx Only
</p>
<p>AMERICAN REGENT, INC.
</p>
<p>SHIRLEY, NY  11967
</p>
<div class="Figure">
<a name="f03"></a><img alt="PRINCIPAL DISPLAY PANEL 15 mL Label
" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=50936b86-2879-4b88-8b15-895afa82e6bf&amp;name=pot00-0000-03.jpg">
</div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="s16"></a><a name="section-15"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - 50 mL Label
</h1>
<p class="First">NDC 0517-2350-25
</p>
<p>POTASSIUM PHOSPHATES INJECTION, USP
</p>
<p>150 mM/50 mL Phosphorus
</p>
<p>220 mEq/50 mL Potassium
</p>
<p>50 mL SINGLE DOSE VIAL
</p>
<p>FOR IV USE AFTER DILUTION
</p>
<p>Rx Only
</p>
<p>AMERICAN REGENT, INC.
</p>
<p>SHIRLEY, NY  11967
</p>
<div class="Figure">
<a name="f04"></a><img alt="PRINCIPAL DISPLAY PANEL 50 mL Label
" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=50936b86-2879-4b88-8b15-895afa82e6bf&amp;name=pot00-0000-04.jpg">
</div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>POTASSIUM PHOSPHATES 		
					</strong><br><span class="contentTableReg">potassium phosphate, monobasic and potassium phosphate, dibasic injection, solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0517-2305</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAVENOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>POTASSIUM PHOSPHATE, MONOBASIC</strong> (PHOSPHORUS) </td>
<td class="formItem">POTASSIUM PHOSPHATE, MONOBASIC</td>
<td class="formItem">224 mg  in 1 mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>POTASSIUM PHOSPHATE, DIBASIC</strong> (PHOSPHORUS) </td>
<td class="formItem">POTASSIUM PHOSPHATE, DIBASIC</td>
<td class="formItem">236 mg  in 1 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>water</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0517-2305-25</td>
<td class="formItem">25  in 1 TRAY</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">5 mL in 1 VIAL, SINGLE-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">unapproved drug other</td>
<td class="formItem"></td>
<td class="formItem">11/19/1989</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>POTASSIUM PHOSPHATES 		
					</strong><br><span class="contentTableReg">potassium phosphate, monobasic and potassium phosphate, dibasic injection, solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0517-2315</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAVENOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>POTASSIUM PHOSPHATE, MONOBASIC</strong> (PHOSPHORUS) </td>
<td class="formItem">POTASSIUM PHOSPHATE, MONOBASIC</td>
<td class="formItem">224 mg  in 1 mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>POTASSIUM PHOSPHATE, DIBASIC</strong> (PHOSPHORUS) </td>
<td class="formItem">POTASSIUM PHOSPHATE, DIBASIC</td>
<td class="formItem">236 mg  in 1 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>water</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0517-2315-25</td>
<td class="formItem">25  in 1 TRAY</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">15 mL in 1 VIAL, SINGLE-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">unapproved drug other</td>
<td class="formItem"></td>
<td class="formItem">11/19/1989</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>POTASSIUM PHOSPHATES 		
					</strong><br><span class="contentTableReg">potassium phosphate, monobasic and potassium phosphate, dibasic injection, solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0517-2350</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAVENOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>POTASSIUM PHOSPHATE, MONOBASIC</strong> (PHOSPHORUS) </td>
<td class="formItem">POTASSIUM PHOSPHATE, MONOBASIC</td>
<td class="formItem">224 mg  in 1 mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>POTASSIUM PHOSPHATE, DIBASIC</strong> (PHOSPHORUS) </td>
<td class="formItem">POTASSIUM PHOSPHATE, DIBASIC</td>
<td class="formItem">236 mg  in 1 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>water</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0517-2350-25</td>
<td class="formItem">25  in 1 TRAY</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">50 mL in 1 VIAL, SINGLE-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">unapproved drug other</td>
<td class="formItem"></td>
<td class="formItem">11/19/1989</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>American Regent, Inc.
							(622781813)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Luitpold Pharmaceuticals, Inc.</td>
<td class="formItem"></td>
<td class="formItem">002033710</td>
<td class="formItem">MANUFACTURE, LABEL, PACK, STERILIZE</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 2/2011<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>c95adfb7-d385-4504-8353-6983517e5513</div>
<div>Set id: 50936b86-2879-4b88-8b15-895afa82e6bf</div>
<div>Version: 1</div>
<div>Effective Time: 20110215</div>
</div>
</div> <div class="DistributorName">American Regent, Inc.</div></p>
</body></html>
